Literature DB >> 36042058

Reply: Computerised tomography features of giant cell tumour of the knee are associated with local recurrence after extended curettage.

Lenian Zhou1, Hongyi Zhu1, Changqing Zhang2,3, Ting Yuan4.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 36042058     DOI： 10.1007/s00264-022-05548-1

Source DB:  PubMed          Journal:  Int Orthop        ISSN： 0341-2695            Impact factor:   3.479


× No keyword cloud information.
  6 in total

1.  Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.

Authors:  Sant Chawla; Jean-Yves Blay; Piotr Rutkowski; Axel Le Cesne; Peter Reichardt; Hans Gelderblom; Robert J Grimer; Edwin Choy; Keith Skubitz; Leanne Seeger; Scott M Schuetze; Robert Henshaw; Tian Dai; Danielle Jandial; Emanuela Palmerini
Journal:  Lancet Oncol       Date:  2019-11-06       Impact factor: 41.316

2.  Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.

Authors:  David Thomas; Robert Henshaw; Keith Skubitz; Sant Chawla; Arthur Staddon; Jean-Yves Blay; Martine Roudier; Judy Smith; Zhishen Ye; Winnie Sohn; Roger Dansey; Susie Jun
Journal:  Lancet Oncol       Date:  2010-02-10       Impact factor: 41.316

3.  Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage.

Authors:  Costantino Errani; Shinji Tsukamoto; Giulio Leone; Alberto Righi; Manabu Akahane; Yasuhito Tanaka; Davide Maria Donati
Journal:  J Bone Joint Surg Am       Date:  2018-03-21       Impact factor: 5.284

4.  Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.

Authors:  Sant Chawla; Robert Henshaw; Leanne Seeger; Edwin Choy; Jean-Yves Blay; Stefano Ferrari; Judith Kroep; Robert Grimer; Peter Reichardt; Piotr Rutkowski; Scott Schuetze; Keith Skubitz; Arthur Staddon; David Thomas; Yi Qian; Ira Jacobs
Journal:  Lancet Oncol       Date:  2013-07-16       Impact factor: 41.316

5.  Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?

Authors:  Guido Scoccianti; Francesca Totti; Maurizio Scorianz; Giacomo Baldi; Giuliana Roselli; Giovanni Beltrami; Alessandro Franchi; Rodolfo Capanna; Domenico Andrea Campanacci
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

6.  Computerised tomography features of giant cell tumour of the knee are associated with local recurrence after extended curettage.

Authors:  Lenian Zhou; Hongyi Zhu; Shanyi Lin; Hanqiang Jin; Zhaoyuan Zhang; Yang Dong; Qingcheng Yang; Changqing Zhang; Ting Yuan
Journal:  Int Orthop       Date:  2021-11-16       Impact factor: 3.479
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.